Evidence map›Paper›PMID 32414071›Full record

ReviewJournal of clinical medicine2020

Recommendations for Standards of Network Care for Patients with Parkinson's Disease in Germany.

Tino Prell, Frank Siebecker, Michael Lorrain, Carsten Eggers, Stefan Lorenzl, Jochen Klucken, Tobias Warnecke, Carsten Buhmann, Lars Tönges, Reinhard Ehret and 2 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Multidisciplinary care in Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Article
  8. Review
  9. Review
  10. Understanding support systems for Parkinson's disease management in community settings: A cross-national qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  11. Article
  12. Disease modification in Parkinsonism: obstacles and ways forward.Journal of neural transmission (Vienna, Austria : 1996) · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Building a Parkinson-Network-Experiences from Germany.Journal of clinical medicine · 2020
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tino PrellDepartment of Neurology, Jena University Hospital, 07740 Jena, Germany.
Frank SiebeckerPraxis Neurologie, 48291 Telgte, Germany.
Michael LorrainNervenarztpraxis Gerresheim-Pempelfort, 40477 Düsseldorf, Germany.
Carsten EggersDepartment of Neurology, University Hospital Marburg, 35037 Marburg, Germany.
Stefan LorenzlProfessorship for Palliative Care, Paracelsus Medical University, 5020 Salzburg, Austria, Department of Palliative Medicine, Ludwig-Maximilians-University Munich, 81377 Munich, Germany.
Jochen KluckenDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Tobias WarneckeDepartment of Neurology, University of Muenster, 48149 Münster, Germany.
Carsten BuhmannDepartment of Neurology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Lars TöngesDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44801 Bochum, Germany.
Reinhard EhretPraxis Neurologie, 12163 Berlin, Germany.
Ingmar WellachOffice for Neurology and Psychiatry Hamburg Walddörfer, Wiesenkamp 22 c, 22359 Hamburg, Germany.
Martin WolzDepartment of Neurology, Elblandklinikum Meißen, 01662 Meißen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although our understanding of Parkinson´s disease (PD) has improved and effective treatments are available, caring for people with PD remains a challenge. The large heterogeneity in terms of motor symptoms, nonmotor symptoms, and disease progression makes tailored individual therapy and individual timing of treatment necessary. On the other hand, only limited resources are available for a growing number of patients, and the high quality of treatment cannot be guaranteed across the board. At this point, networks can help to make better use of resources and improve care. The working group PD Networks and Integrated Care, part of the German Parkinson Society, is entrusted to convene clinicians, therapists, nurses, researchers, and patients to promote the development of PD networks. This article summarizes the work carried out by the working group PD Networks and Integrated Care in the development of standards of network care for patients with PD in Germany.

Indexed as

advanced care planningday clinicmultimodal complex treatmentnetworkstelemedicine

Identifiers

PMID32414071
PMCPMC7290836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.